We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.83B
AUM Growth
+$2.65M
Cap. Flow
-$10.6M
Cap. Flow %
-0.58%
Top 10 Hldgs %
65.56%
Holding
139
New
2
Increased
13
Reduced
62
Closed
5

Top Buys

Rank Stock Value
1
AL
Air Lease Corp
AL
+$12.9M
2
CLB icon
Core Laboratories
CLB
+$8.57M
3
CME icon
CME Group
CME
+$433K
4
IONS icon
Ionis Pharmaceuticals
IONS
+$378K
5
GLW icon
Corning
GLW
+$344K

Sector Composition

Rank Sector Weight
1 Healthcare 25.96%
2 Industrials 25.48%
3 Technology 11.61%
4 Financials 10.62%
5 Energy 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$158M 8.63%
2,283,232
-78,787
-3% -$5.54M
MTD icon
2
Mettler-Toledo International
MTD
$27B
$143M 7.77%
563,204
-2,092
-0.4% -$503K
WAB icon
3
Wabtec
WAB
$50.8B
$137M 7.45%
1,653,722
-109,565
-6% -$8.44M
ADP icon
4
Automatic Data Processing
ADP
$102B
$136M 7.44%
1,960,679
-4,430
-0.2% -$302K
PCP
5
DELISTED
PRECISION CASTPARTS CORP
PCP
$117M 6.38%
463,957
+578
+0.1% +$148K
DCI icon
6
Donaldson
DCI
$10.8B
$115M 6.29%
2,726,195
-25,544
-0.9% -$1.07M
IDXX icon
7
Idexx Laboratories
IDXX
$43.9B
$109M 5.97%
1,638,650
-708
-0% -$45K
VAR
8
DELISTED
Varian Medical Systems, Inc.
VAR
$97M 5.29%
1,330,210
-3,989
-0.3% -$287K
CLB icon
9
Core Laboratories
CLB
$518M
$96.5M 5.26%
577,440
+48,165
+9% +$8.57M
SIAL
10
DELISTED
SIGMA - ALDRICH CORP
SIAL
$93.3M 5.08%
919,016
-1,203
-0.1% -$117K
FEIC
11
DELISTED
FEI COMPANY
FEIC
$78M 4.25%
859,226
+1,163
+0.1% +$102K
AL
12
DELISTED
Air Lease Corp
AL
$76.1M 4.15%
1,973,735
+337,350
+21% +$12.9M
CME icon
13
CME Group
CME
$92.3B
$73.5M 4.01%
1,035,738
+6,145
+0.6% +$433K
V icon
14
Visa
V
$689B
$48.2M 2.63%
914,112
+4,104
+0.5% +$215K
WEX icon
15
WEX
WEX
$6.17B
$39.5M 2.15%
376,104
-10,928
-3% -$1.04M
TROW icon
16
T. Rowe Price
TROW
$25.5B
$33.1M 1.81%
392,522
-4,069
-1% -$332K
ATR icon
17
AptarGroup
ATR
$8.51B
$31.4M 1.71%
468,778
-433
-0.1% -$28.8K
COST icon
18
Costco
COST
$422B
$29.2M 1.59%
253,162
-14,670
-5% -$1.68M
INTC icon
19
Intel
INTC
$462B
$25M 1.36%
808,971
-1,850
-0.2% -$50.7K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.07T
$23.4M 1.28%
185,040
-2,766
-1% -$350K
XOM icon
21
ExxonMobil
XOM
$642B
$21.9M 1.2%
217,901
-30,410
-12% -$3.07M
KO icon
22
Coca-Cola
KO
$362B
$14.2M 0.77%
334,665
-17,404
-5% -$706K
JNJ icon
23
Johnson & Johnson
JNJ
$641B
$10.5M 0.57%
99,979
-942
-0.9% -$95.2K
MKC icon
24
McCormick & Company Non-Voting
MKC
$13.6B
$8.12M 0.44%
226,734
-3,530
-2% -$126K
GILD icon
25
Gilead Sciences
GILD
$162B
$7.19M 0.39%
86,756

Similar funds

Capital Counsel's Q2 2014 Portfolio in Review

As of Q2 2014, Capital Counsel held 139 positions worth $1.83B, up 0.14% from $1.83B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Capital Counsel's Q2 2014 filing shows 2 new, 13 increased, 62 reduced and 5 closed positions. Its largest new stake was Ionis Pharmaceuticals: 12,000 shares worth $413K. The largest sale was Wabtec, an estimated $8.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.

  • Capital Counsel's largest Q2 2014 buy was Ionis Pharmaceuticals: 12,000 shares worth $413K.
  • Capital Counsel added most to Air Lease Corp in Q2 2014, an estimated $12.9M increase.
  • Capital Counsel's biggest Q2 2014 reduction was Wabtec, cutting an estimated $8.44M.
  • Capital Counsel fully exited Cenovus Energy in Q2 2014, selling an estimated $712K.
  • Capital Counsel's ten largest holdings make up 66% of its $1.83B portfolio in Q2 2014.
  • Capital Counsel opened 2 new positions and closed 5 in Q2 2014.
  • Capital Counsel's portfolio value rose 0.14% quarter-over-quarter to $1.83B.

Based on Capital Counsel's 13F filing for Q2 2014, filed 12 Aug 2014.